Technology | March 31, 2011

Oncology Information System Features New Interface

March 31, 2011 – An oncology information system now includes an interface to radiotherapy systems. Elekta’s Mosaiq version 2.20 now has an interface to Xstrahl’s superficial and orthovoltage radiotherapy systems, enabling users of these therapy machines to prepare, deliver and record treatments via Mosaiq.

The Xstrahl family of treatment systems treats superficial tumors and benign lesions (e.g., basal cell and squamous cell carcinomas, keloid scars and dermatological conditions) with low-energy radiation.

The first two users, Sequoia Hospital in Redwood City, Calif., and St. James’s University Hospital, in Leeds, U.K., have reported success at their institutions.

“Mosaiq 2.20 is recording and verifying the treatments we’re giving patients, which is very important to us,” says Helen Monk, manager, radiation oncology at Sequoia Hospital. “Mosaiq helps ensure that every step we’re taking is correct. If a setting or filter has somehow been set incorrectly on the Xstrahl system, the machine will not turn on because it does not match what we set in Mosaiq. If you’re working by yourself, it’s nice to have that added comfort knowing that Mosaiq is double-checking everything you do to ensure safety.”

St. James’s University Hospital’s Peter Enever, advanced practitioner, agrees with the added assurance of safety that the new interface brings.

“You can’t get the combination of filters and applicators wrong,” he said. “The intelligent ‘engine’ in Mosaiq automatically drives the workflow and checks that each step has been done correctly. From our point of view that is a very good safety feature and it gives users added confidence in what they’re doing.”

Enever added that the interface’s similarity to that of a linear accelerator made training literally a five-minute process. “It looks and behaves exactly the same way as a linac interface,” he said. “St. James’s Institute of Oncology’s aspiration to achieve a single integrated patient pathway has moved one step closer with the introduction of the MOSAIQ-Xstrahl interface.”

For more information:

Related Content

IBA Releases Razor Nano Ionization Chamber
News | Proton Therapy | September 22, 2017
September 22, 2017 — IBA (Ion Beam Applications S.A.) announced the release of the Razor Nano Chamber, the smallest a
Penn Medicine Treats World's First Patient on Varian's Halcyon System
News | Radiation Therapy | September 22, 2017
September 22, 2017 — Varian Medical Systems announced a patient at Penn Medicine, with head & neck cancer, became
BrainLAB Announces FDA Clearance For Two New Indication-Specific Radiosurgery Software Applications
Technology | Treatment Planning | September 21, 2017
Brainlab announced that it has received U.S. Food and Drug Administration (FDA) clearance for Elements Spine SRS and...
Accuray Showcases CyberKnife and Radixact Systems at ASTRO 2017
News | Radiation Therapy | September 21, 2017
Accuray Inc. announced that data and first-hand experience with its advanced CyberKnife and Radixact Systems will be...
RayCare Oncology Information System Being Shown at ASTRO 2017
News | Radiation Therapy | September 20, 2017
RaySearch will be exhibiting its next-generation oncology information system (OIS) RayCare, among other highlights, at...
ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients
News | Proton Therapy | September 20, 2017
ProCure Proton Therapy Center in Somerset, N.J., recently celebrated the five-year cancer-free milestone for the first...
Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017
News | Radiation Therapy | September 19, 2017
Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition...
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Overlay Init